as on February 2, 2026 at 2:06 pm IST
Day's Low
Day's High
2.76%
Downside
5.21%
Upside
52 Week's Low
52 Week's High
65.08%
Downside
5.52%
Upside
as on February 2, 2026 at 2:06 pm IST
Market Cap
₹1,086.54 Cr
Return on Equity (ROE)
8.1
PE Ratio (TTM)
14.24
Return on capital employed (ROCE)
11.75
Industry PE ratio
40.1
Beta (LTM)
1.14
P/B Ratio
0.68
Dividend Yield
0PEG Ratio
0.46
Quarterly Earnings Growth YOY
30.51
EPS (TTM)
33.9
Sector
Pharmaceuticals
Book Value
419.65
Technical Analysis
Bullish
View Technical Analysis
as on February 2, 2026 at 2:06 pm IST
Venus Remedies in the last 5 years
Lowest (-45.34x)
September 23, 2020
Today (14.24x)
February 1, 2026
Industry (40.10x)
February 1, 2026
Highest (21.70x)
December 28, 2023
Today’s Price to Earnings Ratio: 14.24x
Compare market cap, revenue, PE, and other key metrics of Venus Remedies with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 1,086.54 | 76.45% | 0.50 | 45 | 647 | |
| NA | 12.00 | -7.67% | 0.00 | NA | 51 | |
| NA | 130.72 | -0.41% | 0.74 | 9 | 96 | |
| NA | 90.12 | -0.08% | 0.00 | 2 | 44 | |
| NA | 10.10 | 26.3% | 0.00 | NA | 13 |
Get share price movements and forecasts by analysts on Venus Remedies.
Source: S&P Global Market Intelligence
Search interest for Venus Remedies Ltd Stock has decreased by -62% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Venus Remedies.
Venus Remedies Ltd’s net profit jumped 30.51% since last year same period to ₹25.58Cr in the Q3 2025-2026. On a quarterly growth basis, Venus Remedies Ltd has generated 27.07% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2013, Venus Remedies Ltd has declared dividend of ₹3.00 per share on 20 May 2013 - translating a dividend yield of 0.73%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 3 quarters, 9.6 Cr → 25.58 Cr (in ₹), with an average increase of 36.8% per quarter
Price Rise
![]()
In the last 7 days, VENUSREM stock has moved up by 8.7%
Best in 1 Year
![]()
In the last 1 year, VENUSREM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Best in 3 Years
![]()
In the last 3 years, VENUSREM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
FII Holding Up
![]()
Foreign Institutions have increased holdings from 1.86% to 2.26% in Dec 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 41.76% of holdings in Dec 2025 quarter
Retail Holding Down
![]()
Retail Investor have decreased holdings from 55.63% to 54.96% in Dec 2025 quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 194.46 Cr → 182.78 Cr (in ₹), with an average decrease of 6.0% per quarter
| Organisation | Venus Remedies Ltd |
| Headquarters | Panchkula |
| Industry | Pharmaceuticals |
| CEO | Pawan Chaudhary |
| E-voting on shares | Click here to vote |
Venus Remedies share price today stands at ₹796 as on . Venus Remedies share today touched a day high of ₹837.45 and a low of ₹774.
Venus Remedies touched a 52 week high of ₹839.9 and a 52 week low of ₹277.95. Venus Remedies share price today i.e. is trending at ₹796, which is -5.23% down from its 52 week high and 186.38% up from its 52 week low.
Venus Remedies market capitalisation is ₹1,086.54 Cr as on .
To buy Venus Remedies shares, you need to follow these steps:
Venus Remedies trading volume is 17.66K as on . This means that 17.66K shares of Venus Remedies were bought and sold on the stock market during today's trading session.